CSRM617 HYDROCHLORIDE

Biochem/physiol Actions

CSRM617 is an ONECUT2 (OC2) inhibitor that directly targets OC2 HOX domain (KD = 7.43 µM) and disrupts OC2 target genes promoter binding. CSRM617 blocks OC2-dependent prostate cancer growth in cultures (IC50 = 4-50 µM; 48 h) via apoptosis induction (fold of untreated annexin V population = 2.3/10 µM, 3.5/20 µM; 22Rv1) and exhibits in vivo efficacy against metastases as well as the growth of established 22Rv1 tumor in mice in vivo (50 mg/kg/day ip.).

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3576575 CSRM617 HYDROCHLORIDE white to beige SIGMA-ALDRICH −20°C H2O: 2 mg/mL, clear powder ≥98% (HPLC)
£486.11 (exc VAT) per EACH
-
+
3576576 CSRM617 HYDROCHLORIDE white to beige SIGMA-ALDRICH −20°C H2O: 2 mg/mL, clear powder ≥98% (HPLC)
£119.93 (exc VAT) per EACH
-
+